S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study
PHASE2CompletedINTERVENTIONAL
Enrollment
57
Participants
Timeline
Start Date
November 30, 2011
Primary Completion Date
December 31, 2015
Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG
S1 combined with cisplatin
Trial Locations (1)
200032
Cancer hospital Fudan University, Shanghai
All Listed Sponsors
lead
Fudan University
OTHER
NCT01854749 - S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study | Biotech Hunter | Biotech Hunter